Staab Thomas R II
- SEC CIK
- 0001230708
In the past year, 1 open-market purchase filing worth $11.0K and no sales.
Current role at each company
- TENX Tenax Therapeutics, Inc.Chief Financial Officeras of Sep 15, 2026
- LNSR LENSAR, Inc.Chief Financial Officeras of May 8, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $11.0K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$11.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Staab Thomas R II as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TENX Tenax Therapeutics, Inc.
Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 (view filing)9:30 PM ET | Sep 11 | 4 days | Staab Thomas R IIChief Financial Officer | PPurchase | +5.67K | $1.94 | +$11.0K | +56.8%15.7K after |
LNSR LENSAR, Inc.
Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 7, 2022 (view filing) | Dec 6-7 | 1 day | Staab Thomas R IIChief Financial Officer | PPurchase | +2.75K | $3.16 | +$8.70K | +2.1%135.1K after | 2 lots |